SOLV · Solventum Corp
Market Cap
$15.72B
Shares
170.22M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Bryan Hanson | Chief Executive Officer | $20,139,981 |
| Heather Knight | Chief Commercial Officer | $7,917,906 |
| Wayde McMillan | Chief Financial Officer | $6,165,583 |
| Christopher Barry | Former EVP and Group President, Medical Surgical | $4,232,003 |
| Marcela A. Kirberger | Chief Corporate & Legal Officer | $3,594,017 |
| Amy L. Landucci | Chief Information & Digital Officer | $3,464,975 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Bryan Hanson | Chief Executive Officer | $39,959,767 |
| Wayde McMillan | Chief Financial Officer | $10,321,753 |
| Christopher Barry | EVP and Group President, Medical Surgical | $9,763,527 |
| Amy L. Landucci | Chief Information & Digital Officer | $9,070,517 |
| Tammy L. Gomez | Chief Human Resource Officer | $4,957,367 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Neil Zieselman | Senior Vice President, Controller and Chief Accounting Officer | Appointed | 2026-07-20 |
Key facts
CIK
1964738
CUSIP
83444M101
13F (30d)
532 filings
519 filers
Visit website
Investor relations